# PROBE (NCT04510597)

> Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04510597
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: SWOG Cancer Research Network
- Conditions: Metastatic Clear Cell Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Stage IV Renal Cell Cancer AJCC v8
- Interventions: Cytoreductive Nephrectomy; Active Comparator
- Enrollment: 364
- Primary outcome: Overall survival

## Indexed commentary on PROBE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=probe-nct04510597